ATM and cancer: The high functional overlap between the ATM perturbations for A-EJ is consistent with kinase-dead ATM versus deficiency having no overt difference in NHEJ-mediated V(D)J recombination despite kinase dead dominant effects to block topoisomerase I lesion resolution during replication as a putative causal mechanism for viability and cancer predisposition differences (71, 72).